Article
First-In-Human Trials in Malaysia: Regulatory and Clinical Readiness
Aug 04, 2026

Get instant access

Download

Malaysia is an emerging hub for early-phase clinical development. With a population of over 34 million, Malaysia’s ethnogenetic diversity provides a natural stratification for early-phase clinical trials.

Insights from a recent webinar, “First-In-Human Trials in Malaysia: Regulatory and Clinical Readiness” highlight several key considerations shaping the country’s readiness for early-phase studies — spanning site capabilities, regulatory expectations, and operational efficiencies.

You may also be interested in

White Paper
Malaysia: The New Destination for Early Phase Trials

Malaysia’s emergence as a leading hub for early phase clinical trials, offering global sponsors access to accredited sites, diverse populations, and streamlined regulatory pathways.
Insight Brief
Southeast Asia and Pakistan Overview: The Emerging Hub for Clinical Trial Scale Up

How these emerging markets support efficient patient recruitment and create vast opportunities to accelerate trial growth and innovation across multiple therapeutic areas.
White Paper
Enhancing the Assessment of Medical Devices in Malaysia

A comprehensive value-based approach
Press Release
IQVIA Malaysia Awarded CRO of the Year and Publication of the Year by Clinical Research Malaysia
Prev
Next
Contact Us